Last 7 days
-5.3%
Last 30 days
-27.1%
Last 90 days
-17.7%
Trailing 12 Months
-56.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-15 | Carpenter Rick | sold (taxes) | -3,066 | 21.75 | -141 | chief technical officer |
2023-09-15 | McGroddy-Goetz Kathleen | bought | 21,450 | 21.45 | 1,000 | - |
2023-09-15 | Carpenter Rick | acquired | - | - | 406 | chief technical officer |
2023-08-28 | Sheridan John F | sold (taxes) | -7,685 | 27.06 | -284 | president & ceo |
2023-08-28 | BERGER DAVID B | sold (taxes) | -3,815 | 27.06 | -141 | evp & chief operating officer |
2023-08-28 | Leal James | acquired | - | - | 310 | chief manufacturing officer |
2023-08-28 | HANSEN BRIAN B | acquired | - | - | 407 | evp & chief commercial officer |
2023-08-28 | HANSEN BRIAN B | sold (taxes) | -3,653 | 27.06 | -135 | evp & chief commercial officer |
2023-08-28 | BERGER DAVID B | acquired | - | - | 407 | evp & chief operating officer |
2023-08-28 | Gasser Elizabeth Anne | acquired | - | - | 372 | evp, chief strategy officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | new | - | 317,246 | 317,246 | -% |
2023-09-20 | BARCLAYS PLC | reduced | -34.39 | -2,472,000 | 1,622,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 1.00 | -7,912 | 12,393 | -% |
2023-08-24 | Alberta Investment Management Corp | new | - | 4,644,170 | 4,644,170 | 0.04% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 81.13 | 40,702 | 471,168 | -% |
2023-08-21 | BOKF, NA | sold off | -100 | -491,015 | - | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 39.96 | -95,000 | 523,000 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.36 | -1,338,150 | 1,925,680 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 13.22 | -189,358 | 410,059 | -% |
2023-08-18 | Legato Capital Management LLC | added | 35.55 | -79,535 | 360,149 | 0.05% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jun 12, 2023 | fmr llc | - | 0 | SC 13G/A | |
May 10, 2023 | capital world investors | 10.0% | 6,473,192 | SC 13G/A | |
Apr 10, 2023 | vanguard group inc | 10.92% | 7,047,477 | SC 13G/A | |
Apr 06, 2023 | blackrock inc. | 14.3% | 9,206,880 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 7.7% | 4,978,524 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.53% | 6,127,229 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.9% | 6,345,760 | SC 13G | |
Jul 11, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 5.6% | 3,543,503 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 19, 2023 | 4 | Insider Trading | |
Sep 19, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 108.3B | 19.5B | 3.38% | 36.58% | 39.99 | 5.57 | 10.36% | 30.30% |
ISRG | 101.2B | 6.7B | -0.75% | 50.83% | 71.05 | 15.19 | 11.75% | -0.66% |
BSX | 77.5B | 13.4B | 6.45% | 36.39% | 85 | 5.78 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -4.29% | 12.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.3B | 5.7B | -8.22% | -17.24% | 30.48 | 7.49 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.65 | 10.11 | 16.30% | 250.21% |
SWAV | 7.1B | 616.6M | -12.54% | -24.86% | 29.24 | 11.56 | 69.52% | 343.68% |
GMED | 5.1B | 1.1B | -6.10% | -12.07% | 24.23 | 4.65 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -21.20% | -33.94% | -26.32 | 5.78 | 24.99% | 24.09% |
TNDM | 1.3B | 790.3M | -27.09% | -56.49% | -5.97 | 1.69 | 3.21% | -1604.53% |
SMALL-CAP | ||||||||
ATEC | 1.6B | 421.8M | -15.15% | 56.11% | -9.32 | 3.69 | 44.49% | -2.43% |
AVNS | 947.4M | 780.7M | -7.75% | -9.65% | -26.32 | 1.21 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 609.7M | 162.9M | -27.67% | -61.65% | -11.53 | 3.74 | 42.67% | 12.82% |
-18.2%
-13.9%
-42.5%
100%
81.9%
46.5%
Y-axis is the maximum loss one would have experienced if Tandem Diabetes Care was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -0.5% | 790,349,000 | 794,694,000 | 801,218,000 | 790,712,000 | 765,792,000 | 737,669,000 | 702,799,000 | 660,868,000 | 604,844,000 | 541,941,000 | 498,830,000 | 439,163,000 | 410,217,000 | 394,236,000 | 362,305,000 | 330,106,000 | 281,713,000 | 222,584,000 | 183,866,000 | 147,961,000 | 128,700,000 |
Gross Profit | -0.1% | 404,590,000 | 404,801,000 | 412,987,000 | 411,193,000 | 403,513,000 | 394,021,000 | 376,215,000 | 353,042,000 | 321,610,000 | 283,546,000 | 260,520,000 | 230,236,000 | 215,606,000 | 211,120,000 | 194,212,000 | 175,475,000 | 146,588,000 | 111,771,000 | 89,822,000 | 65,755,000 | 55,832,000 |
Operating Expenses | 4.3% | 636,485,000 | 610,127,000 | 505,834,000 | 473,525,000 | 410,632,000 | 383,469,000 | 353,562,000 | 324,465,000 | 301,762,000 | 281,167,000 | 268,477,000 | 254,711,000 | 245,076,000 | 230,418,000 | 210,934,000 | 193,781,000 | 174,599,000 | 151,914,000 | 134,453,000 | 120,528,000 | 108,062,000 |
S&GA Expenses | 4.8% | 369,220,000 | 352,224,000 | 335,681,000 | 309,488,000 | 290,307,000 | 276,216,000 | 261,508,000 | 244,527,000 | 229,832,000 | 213,749,000 | 204,903,000 | 195,947,000 | 190,368,000 | 180,493,000 | 165,735,000 | 152,353,000 | 137,210,000 | 119,273,000 | 105,226,000 | 94,348,000 | 84,967,000 |
R&D Expenses | - | - | - | - | - | 120,325,000 | 107,253,000 | 92,054,000 | 79,938,000 | 71,930,000 | 67,418,000 | 63,574,000 | 58,765,000 | 54,709,000 | 49,926,000 | 45,199,000 | 41,428,000 | 37,389,000 | 32,641,000 | 29,227,000 | 26,181,000 | 23,096,000 |
EBITDA | 100.0% | - | -183,668,000 | -76,239,000 | -44,901,000 | - | 20,810,000 | 31,914,000 | - | - | -13,112,000 | -24,375,000 | -42,328,000 | -37,293,000 | -10,320,000 | -18,904,000 | 6,823,000 | 11,542,000 | -106,310,000 | - | - | - |
EBITDA Margin | 100.0% | - | -0.23 | -0.10 | -0.06 | - | 0.03 | 0.05 | - | - | -0.02 | -0.05 | -0.10 | -0.09 | -0.03 | -0.05 | 0.02 | 0.04 | -0.48 | - | - | - |
Interest Expenses | - | - | - | 4,313,000 | 8,628,000 | - | - | 4,313,000 | 2,874,667 | - | - | 2,707,000 | - | - | - | - | 9,928,000 | 12,042,000 | - | 10,805,000 | 7,846,000 | 8,778,000 |
Earnings Before Taxes | -10.8% | -221,681,000 | -200,052,000 | -92,852,000 | -65,599,000 | -12,499,000 | 4,601,000 | 15,901,000 | 21,738,000 | 6,569,000 | -26,731,000 | -36,282,000 | -50,640,000 | -44,100,000 | -16,412,000 | -24,604,000 | -8,682,000 | -6,048,000 | - | -122,560,000 | - | - |
EBT Margin | 100.0% | - | -0.25 | -0.12 | -0.08 | -0.02 | 0.01 | 0.02 | 0.03 | 0.01 | -0.05 | -0.07 | -0.12 | -0.11 | -0.04 | -0.07 | - | - | - | - | - | - |
Net Income | -10.2% | -224,470,000 | -203,751,000 | -94,593,000 | -67,933,000 | -13,169,000 | 5,895,000 | 15,566,000 | 21,758,000 | 6,556,000 | -24,559,000 | -34,382,000 | -48,730,000 | -42,223,000 | -16,628,000 | -24,753,000 | -23,719,000 | -55,063,000 | -112,910,000 | -122,611,000 | -137,703,000 | -119,492,000 |
Net Income Margin | 100.0% | - | -0.26 | -0.12 | -0.09 | -0.02 | 0.01 | 0.02 | 0.03 | 0.01 | -0.05 | -0.07 | -0.11 | -0.10 | -0.04 | -0.07 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -21,944,000 | 16,367,000 | 30,063,000 | 50,879,000 | 83,175,000 | 97,179,000 | 94,431,000 | 71,186,000 | 49,819,000 | -2,739,000 | -1,186,000 | 9,406,000 | 500,000 | 22,365,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -0.8% | 947 | 954 | 1,053 | 1,048 | 1,037 | 1,015 | 905 | 850 | 795 | 754 | 716 | 673 | 616 | 343 | 326 | 293 | 255 | 215 | 206 | 182 | 158 |
Current Assets | 0.8% | 764 | 758 | 850 | 834 | 835 | 818 | 812 | 755 | 698 | 662 | 637 | 592 | 540 | 281 | 276 | 247 | 213 | 186 | 188 | 163 | 128 |
Cash Equivalents | 2.3% | 131 | 128 | 173 | 124 | 115 | 94.00 | 71.00 | 112 | 99.00 | 121 | 95.00 | 129 | 222 | 74.00 | 51.00 | 46.00 | 38.00 | 40.00 | 42.00 | 32.00 | 51.00 |
Inventory | 12.2% | 148 | 132 | 111 | 105 | 88.00 | 80.00 | 69.00 | 66.00 | 67.00 | 67.00 | 64.00 | 71.00 | 62.00 | 60.00 | 49.00 | 41.00 | 27.00 | 23.00 | 20.00 | 24.00 | 25.00 |
Net PPE | -1.1% | 74.00 | 75.00 | 69.00 | 73.00 | 59.00 | 50.00 | 50.00 | 50.00 | 49.00 | 50.00 | 50.00 | 49.00 | 44.00 | 38.00 | 33.00 | 28.00 | 23.00 | 17.00 | 17.00 | 18.00 | 18.00 |
Liabilities | 0.3% | 617 | 615 | 613 | 626 | 587 | 578 | 472 | 461 | 449 | 441 | 350 | 346 | 349 | 136 | 131 | 126 | 110 | 94.00 | 75.00 | 66.00 | 132 |
Current Liabilities | 2.0% | 175 | 171 | 165 | 174 | 139 | 132 | 132 | 120 | 109 | 103 | 104 | 106 | 114 | 100 | 99.00 | 100 | 84.00 | 77.00 | 66.00 | 59.00 | 43.00 |
Shareholder's Equity | -2.8% | 329 | 339 | 440 | 422 | 450 | 437 | 433 | 390 | 346 | 313 | 366 | 327 | 268 | 207 | 195 | 167 | 145 | 121 | 131 | 115 | 26.00 |
Retained Earnings | -4.2% | -888 | -853 | -729 | -713 | -664 | -649 | -634 | -645 | -651 | -655 | -659 | -676 | -666 | -639 | -624 | -627 | -624 | -623 | -600 | -603 | -569 |
Additional Paid-In Capital | 2.3% | 1,219 | 1,192 | 1,171 | 1,140 | 1,118 | 1,090 | 1,068 | 1,035 | 997 | 968 | 1,025 | 1,003 | 934 | 847 | 820 | 794 | 770 | 744 | 731 | 719 | 595 |
Accumulated Depreciation | - | - | - | 56.00 | - | - | - | 49.00 | - | - | - | 39.00 | - | - | - | 30.00 | - | - | - | 26.00 | - | - |
Shares Outstanding | 0.7% | 65.00 | 65.00 | 65.00 | 64.00 | 64.00 | 64.00 | 64.00 | 63.00 | 63.00 | 62.00 | 62.00 | 62.00 | 60.00 | 60.00 | 59.00 | 59.00 | 58.00 | 58.00 | 48.00 | 56.00 | 51.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -72.1% | 5.00 | 18.00 | 50.00 | 64.00 | 74.00 | 96.00 | 111 | 107 | 87.00 | 74.00 | 25.00 | 29.00 | 37.00 | 25.00 | 42.00 | 37.00 | 10.00 | -0.17 | -8.32 | -34.09 | -49.65 |
Share Based Compensation | 3.7% | 91.00 | 88.00 | 85.00 | 78.00 | 71.00 | 66.00 | 61.00 | 57.00 | 54.00 | 56.00 | 58.00 | 64.00 | 68.00 | 64.00 | 58.00 | 50.00 | 42.00 | 32.00 | 24.00 | 16.00 | 8.00 |
Cashflow From Investing | -40.1% | 1.00 | 2.00 | 33.00 | -79.43 | -104 | -175 | -186 | -169 | -268 | -335 | -296 | -257 | -141 | -24.82 | -56.95 | -42.64 | -67.28 | -80.45 | -90.74 | -85.57 | -39.00 |
Cashflow From Financing | -32.0% | 9.00 | 13.00 | 17.00 | 27.00 | 46.00 | 52.00 | 52.00 | 45.00 | 56.00 | 307 | 314 | 312 | 289 | 34.00 | 24.00 | 20.00 | 35.00 | 48.00 | 117 | 130 | 112 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Sales | $ 195,917 | $ 200,262 | $ 365,300 | $ 376,169 |
Cost of sales | 94,182 | 98,316 | 180,658 | 183,130 |
Gross profit | 101,735 | 101,946 | 184,642 | 193,039 |
Operating expenses: | ||||
Selling, general and administrative | 97,610 | 80,614 | 187,424 | 153,885 |
Research and development | 42,933 | 33,571 | 85,093 | 66,731 |
Acquired in-process research and development expenses | 0 | 0 | 78,750 | 0 |
Total operating expenses | 140,543 | 114,185 | 351,267 | 220,616 |
Operating loss | (38,808) | (12,239) | (166,625) | (27,577) |
Other income (expense), net: | ||||
Interest income and other, net | 5,784 | 826 | 11,649 | 1,241 |
Interest expense | (1,605) | (1,537) | (3,239) | (3,053) |
Total other income (expense), net | 4,179 | (711) | 8,410 | (1,812) |
Loss before income taxes | (34,629) | (12,950) | (158,215) | (29,389) |
Income tax expense | 1,146 | 2,106 | 1,433 | 382 |
Net loss | (35,775) | (15,056) | (159,648) | (29,771) |
Other comprehensive income (loss): | ||||
Unrealized gain (loss) on short-term investments | (298) | (1,124) | 1,451 | (3,641) |
Foreign currency translation losses | (802) | (97) | (827) | (25) |
Comprehensive loss | $ (36,875) | $ (16,277) | $ (159,024) | $ (33,437) |
Net loss per share - basic (in dollars per share) | $ (0.55) | $ (0.23) | $ (2.47) | $ (0.47) |
Net loss per share - diluted (in dollars per share) | $ (0.55) | $ (0.24) | $ (2.47) | $ (0.47) |
Weighted average shares used to compute basic net loss per share (in shares) | 64,830 | 64,077 | 64,690 | 63,979 |
Weighted average shares used to compute diluted net loss per share (in shares) | 64,830 | 64,078 | 64,690 | 63,980 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 130,751 | $ 172,517 |
Short-term investments | 376,495 | 444,384 |
Accounts receivable, net | 98,714 | 114,717 |
Inventories | 147,599 | 111,117 |
Prepaid and other current assets | 10,745 | 7,241 |
Total current assets | 764,304 | 849,976 |
Property and equipment, net | 73,752 | 68,552 |
Operating lease right-of-use assets | 91,054 | 110,626 |
Other long-term assets | 17,566 | 23,631 |
Total assets | 946,676 | 1,052,785 |
Current liabilities: | ||
Accounts payable | 57,080 | 55,730 |
Accrued expenses | 13,120 | 9,595 |
Employee-related liabilities | 35,473 | 38,682 |
Operating lease liabilities | 17,757 | 13,121 |
Deferred revenue | 23,401 | 18,837 |
Other current liabilities | 27,824 | 29,325 |
Total current liabilities | 174,655 | 165,290 |
Convertible senior notes, net - long-term | 284,128 | 283,232 |
Operating lease liabilities - long-term | 118,400 | 123,524 |
Deferred revenue - long-term | 15,305 | 16,874 |
Other long-term liabilities | 24,954 | 23,918 |
Total liabilities | 617,442 | 612,838 |
Commitments and contingencies (Note 13) | 0 | 0 |
Stockholders’ equity: | ||
Common stock, $0.001 par value; 200,000 shares authorized, 65,062 and 64,513 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively. | 65 | 65 |
Additional paid-in capital | 1,219,199 | 1,170,888 |
Accumulated other comprehensive loss | (1,193) | (1,817) |
Accumulated deficit | (888,837) | (729,189) |
Total stockholders’ equity | 329,234 | 439,947 |
Total liabilities and stockholders’ equity | $ 946,676 | $ 1,052,785 |